Abstract: In one aspect, the invention relates to an immunogenic composition that includes a Clostridium difficile toxoid A and/or a C. difficile toxoid B, and methods of use thereof. In another aspect, the invention relates to a method for eliciting an immune response in a human against a C. difficile infection. The method includes administering to the human an effective dose of a composition, which includes a C. difficile toxoid, wherein the composition is administered at least two times, and wherein the immune response against C. difficile toxin A and/or toxin B is sustained.

Abstract: An unmanned aerial vehicle (UAV) is disclosed that includes a power source. The power source includes: one or more power cells; one or more thermal transfer members that are thermally connected to the one or more power cells; and a heat exchanger that is thermally connected to the one or more thermal transfer members such that the one or more thermal transfer members and the heat exchanger facilitate a transfer of thermal energy between the power source and ambient air to decrease or increase temperature of the power source.

Abstract: A base station is disclosed that is configured for use with a UAV. The base station includes: an enclosure with an outer housing that defines a roof section and an inner housing that is connected to the outer housing; one or more heating elements that are supported by the enclosure and which are configured to heat the roof section; one or more fiducials that are supported by the enclosure; an illumination system that is supported by the enclosure and which is configured to illuminate the one or more fiducials; and a visualization system that is supported by the enclosure.

Abstract: A base station is disclosed for use with an unmanned aerial vehicle (UAV). The base station includes: an enclosure; a cradle that is configured to charge a power source of the UAV during docking with the base station; and a temperature control system that is connected to the cradle and which is configured to vary temperature of the power source of the UAV. The temperature control system includes: a thermoelectric conditioner (TEC); a first air circuit that is thermally connected to the TEC and which is configured to regulate temperature of the TEC; and a second air circuit that is thermally connected to the TEC such that the TEC is located between the first air circuit and the second air circuit. The second air circuit is configured to direct air across the cradle to thereby heat or cool the power source of the UAV when docked with the base station.

Abstract: Organizational systems and associated components and methods for garages, sheds, basements or other spaces that have exposed wall or ceiling elongated members are provided. One such component includes a bracket having a first wall, a second wall facing the first wall and spaced apart from the first wall, and a third wall interconnecting the first and second walls. The first, second and third walls cooperatively define a channel for receiving the elongated member. The bracket includes an interface for releasable attachment of a storage component to the bracket. A clamp foot is movably coupled to the first wall. The clamp foot is translatable between an engaged position and a released position to respectively engage and release the elongated member received in the channel.

Abstract: In one aspect, the invention relates to an immunogenic composition that includes a Clostridium difficile toxoid A and/or a C. difficile toxoid B, and methods of use thereof. In another aspect, the invention relates to a method for eliciting an immune response in a human against a C. difficile infection. The method includes administering to the human an effective dose of a composition, which includes a C. difficile toxoid, wherein the composition is administered at least two times, and wherein the immune response against C. difficile toxin A and/or toxin B is sustained.

Abstract: A medicinal dosage compliance system may comprise a docking station, a container, and transactional information component. The docking station may comprise an interaction portion. The lockable container may be configured to hold medicine for a student, and the container may be configured to operably engage with the interaction portion. The transactional information component may be in operative communication with a computing device accessible by a user. The student and the container may be identified and associated with the identified student. Medication data may be communicated to the transactional information component indicative of a dosing event. The medication data may comprise at least a type of medication, a dosage amount of medicine to be taken by the student and a time when the medicine was taken by the student. A digital medical administration record for the identified person may be configured to record the medication data.

Abstract: The technology described herein relates to autonomous aerial vehicle technology and, more specifically, to autonomous unmanned aerial vehicle with folding collapsible arms. In some embodiments, a UAV including a central body, a plurality of rotor arms, and a plurality of hinge mechanisms is disclosed. The plurality of rotor arms each include a rotor unit at a distal end of the rotor arm. The rotor units are configured to provide propulsion for the UAV. The plurality of hinge mechanisms mechanically attach (or couple) proximal ends of the plurality of rotor arms to the central body. Each hinge mechanism is configured to rotate a respective rotor arm of the plurality of rotor arms about an axis of rotation that is at an oblique angle relative to a vertical median plane of the central body to transition between an extended state and a folded state.

Abstract: In one aspect, the invention relates to an immunogenic composition that includes a Clostridium difficile toxoid A and/or a C. difficile toxoid B, and methods of use thereof. In another aspect, the invention relates to a method for eliciting an immune response in a human against a C. difficile infection. The method includes administering to the human an effective dose of a composition, which includes a C. difficile toxoid, wherein the composition is administered at least two times, wherein the second administration is about 30 days after the first administration, and wherein the immune response against C. difficile toxin A and/or toxin B is sustained.

Abstract: The present invention describes a conically shaped baffle for use in a firearm suppressor or silencer wherein the gas inlet end of the baffle is angled downward and oblong shaped, which not only assist in allowing a higher flow of gas to pass through the inlet, but also directs the gas downward and away from the bore.

Abstract: The present invention describes a suppressor or silencer device for a pistol that does not interfere with a traditional pistol sight, yet is still able to suppress or silence the pistol in substantially equal to or greater efficacy than a traditional suppressor. This is accomplished by attaching an additional chamber on the bottom side of the tubular body (or “bore”) of the suppressor where the bullet is traveling; heated gas behind the bullet travels down into the chamber where its geometry slows the gas down before exiting the chamber.

Abstract: A semiconductor package comprises a first package; a second package that is provided on the first package; and a first interconnect that comprises a bump to couple to the first package and a base material layer to cover the bump, wherein the second package is supported on the base material layer that is coupled to the bump.

Abstract: A semiconductor package comprises a first package; a second package that is provided on the first package; and a first interconnect that comprises a bump to couple to the first package and a base material layer to cover the bump, wherein the second package is supported on the base material layer that is coupled to the bump.

Abstract: A method of facilitating interactive communication between clients providing services and/or products and prospective users thereof. The method provides access to a database of at least one client's user interest data on a network, permits network access to the user interest data by a user via a remote interface, and receives a selection by the user of the client's user interest data and receives entry by the user of user-specific data. Access is provided to processing software which processes the user-specific data and the selected user interest data to produce response data, and at least one recipient nominated by the client is provided with access to equipment which automatically exports the response data.